+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 3Years - 100Years
All Genders
ID00344188

Host Response and Treatment Evaluation in Human Leishmania Infection to Understand Disease Progression and Resistance

Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2026-10-29

400

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research focuses on patients with active Leishmania infection or those suspected of having it. The study aims to diagnose and classify the infection and provide species-based therapy. Researchers want to understand how the infection behaves over time, especially in cases where the disease resists treatment or relapses. The study also examines the bodys response before and after therapy through biopsies and other tissue samples to gain insights into diagnosis, disease development, and treatment response. Participants receive clinical care tailored to their infection, including therapeutic interventions appropriate for their condition. They undergo physical examinations and tissue sample collections such as blood, lesion swabs, mucosal swabs, microbiopsies, and skin biopsies for research. Follow-up visits are scheduled at 3 months, 6 months via phone or telehealth, and 12 months post-treatment, with additional visits as needed based on clinical status. Remote visits and sample submissions are possible when local physicians are involved. During the study, participants undergo clinical and immunologic assessments to monitor their response to treatment, with long-term follow-up extending beyond one year if necessary. Samples collected are used for laboratory research, including immune system evaluations and genomic analysis of the parasite. The main outcomes measured include immune function, parasite genetics, and clinical course characteristics related to resistance or relapse. The study duration typically lasts about one year after successful treatment, with continued monitoring as clinically indicated.

CONDITIONS

Brief Title

Diagnosis and Treatment of Leishmania Infections

Research Team

E

Elise M O'Connell, M.D.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here